NFE2L2 and cancer: Together, our study proposes that KEAP1-NRF2 controls both the SLC7A11-GSH-GPX4 and CoQ-FSP1 arms for ferroptosis defense; consequently, if one arm is disabled, KEAP1 deficient cancer cells can still utilize the other arm to defend against ferroptosis.